Reconstitution of HLA-A*2402-Restricted Cytomegalovirus-Specific T-Cells Following Stem Cell Transplantation
Cytomegalovirus (CMV)-specific immune reconstitution early after stem cell transplantation (SCT) was evaluated prospectively by detecting CD8+ T-cells, which recognize the peptide QYDPVAALF in the context of HLA-A*2402. Fifteen allogeneic SCT recipients were included in the study. All recipients and donors were seropositive for CMV and had the HLA-A*2402 allele. CMV-specific T-cells were detected as early as 1 month after transplantation, and their numbers increased to peak levels 2 to 5 months after transplantation. The numbers of CMV-specific T-cells in patients who developed grade II to IV acute graft-versus-host disease (GVHD) and received corticosteroids for acute GVHD were low in the early period after allogeneic SCT. There was a trend toward earlier reconstitution of CMV-specific CD8+ T-cells in allogeneic peripheral blood SCT (PBSCT) patients than in allogeneic bone marrow transplantation patients. The contribution of T-cells in the graft to the recovery of CMV-specific immune responses was also suggested by the finding that the reconstitution of CMV-specific CD8+ T-cells was delayed in CD34-selected autologous PBSCT compared with unpurged autologous PBSCT. The reconstitution of CMV-specific CD8+ T-cells was delayed in patients with CMV disease or recurrent CMV reactivation. These observations suggest that the detection of CMV-specific T-cells with an HLA-peptide tetramer is useful to assess immune reconstitution against CMV and to identify patients at risk for CMV disease or recurrent CMV reactivation after SCT.
Key wordsHLA-A*2402 Cytomegalovirus CMV-specific T-cells Stem cell transplantation Tetramer
Unable to display preview. Download preview PDF.
- 1.Zaia JA. Cytomegalovirus infection. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. Malden, Mass: Blackwell Science; 1999;560–583.Google Scholar
- 12.Herr W, Schneider AW, Lohse KH, Meyer zum Büschenfelde KH, Wölfel T. Detection and quantification of blood-derived CD8+ Tlymphocytes secreting tumor necrosis factor α in response to HLA-A2.1-binding melanoma and viral peptide antigens. J Immunol Methods. 1996;191:131–142.CrossRefPubMedGoogle Scholar
- 13.Waldrop SL, Pitcher CJ, Peterson DM, Maino VC, Picker LJ. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest. 1997;99:1739–1750.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Hebart H, Daginik S, Stevanovic S, et al. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-γ-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Blood. 2002;99:3830–3837.CrossRefPubMedGoogle Scholar
- 17.Gratama JW, van Esser JWJ, Lamers CHJ, et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood. 2001;98;1358–1364.CrossRefPubMedGoogle Scholar
- 19.Park MH, Juji T, Tokunaga K. HLA ethnic study of Japanese and Koreans. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Vol 1. Oxford, UK: Oxford University Press; 1992;674–676.Google Scholar
- 20.Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojoberi T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Vol 1. Oxford, UK: Oxford University Press; 1992;1065–1220.Google Scholar
- 25.Machida U, Kami M, Fukui T, et al. Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol. 2000;38:2536–2542. 26. Ljungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. In: Michelson S, Plotkin SA, eds. Multidisciplinary Approach to Understanding Cytomegalovirus Disease. Amsterdam, the Netherlands: Elsevier Science; 1993;233-237.PubMedPubMedCentralGoogle Scholar
- 32.Gillespie GM, Wills MR, Appay V, et al. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8+ T lymphocytes in healthy seropositive donors. J Virol. 2000;74:8140–8150. 33.Noga SJ, Civin CI. Positive stem-cell selection for hematopoietic transplantation. In: Ferrara JLM, Deeg HJ, Burakoff SJ, eds. Graftversus-Host Disease. New York, NY: Marcel Dekker; 1997;717-732.CrossRefPubMedPubMedCentralGoogle Scholar